% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • moneyandstocks moneyandstocks May 9, 2013 1:27 PM Flag

    SRPT A Top Buy Among Funds . LINK

    Seeking Alpha By: Guru Fund Picks
    Sarepta Therapeutics (SRPT), that develops RNA-based therapeutics for the treatment of genetic, infectious and other diseases, in which mega funds together added a net 2.62 million shares in Q4 to their 2.89 million share prior quarter position in the company. In small-cap biotech stocks, SRPT was also a top buy among guru funds in Q4.

47.27+0.35(+0.75%)11:27 AMEDT